FN1 and cancer: PAI-1 inhibition of fibrinolysis, via inactivation of tPA and uPA, leads to maintenance of thrombin activity which is able to interact with Protease-Activated Receptors (PAR) in cancer cells enhancing PAR-dependent proliferation; PAI-1 has also been shown to stimulate fibronectin-dependent cell growth [31].